| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 04/18/2007 | EP1773387A2 Avipox recombinants expressing foot and mouth disease virus genes |
| 04/18/2007 | EP1773386A2 Vaccine compositions and methods |
| 04/18/2007 | EP1773385A2 SKIN IMMUNIZATION USING LT-STa FUSION PROTEINS |
| 04/18/2007 | EP1773384A2 Genetically engineered swine influenza virus and uses thereof |
| 04/18/2007 | EP1773383A2 Antibodies as t cell receptor mimics, methods of production and uses thereof |
| 04/18/2007 | EP1773381A2 Immunosuppressive exosomes |
| 04/18/2007 | EP1773340A2 Pharmaceutical composition of (+)-erythro-mefloquine and its use in the treatment of an inflammatory condition |
| 04/18/2007 | EP1706142B1 Streptococcus phocae vaccine |
| 04/18/2007 | EP1589995B1 Use of avian antibodies |
| 04/18/2007 | EP1476188B1 Method for accessing microbial diversity |
| 04/18/2007 | EP1441761B1 Methods of preventing and treating flavivirus infection in animals |
| 04/18/2007 | EP1434877B1 Chromogenic in situ hybridization methods, kits, and compositions |
| 04/18/2007 | EP1428835B1 Antibody against metastin and use of the same in the diagnosis of pregnancy |
| 04/18/2007 | EP1411977B1 Composition containing bacterial antigens, used for the prophylaxis and the treatment of allergic diseases |
| 04/18/2007 | EP1411970B1 Use of sarp-1 for the treatment and/or prevention of scleroderma |
| 04/18/2007 | EP1401479B1 Detection and therapy of vulnerable plaque with photodynamic compounds |
| 04/18/2007 | EP1379266B1 Modified annexin proteins and prevention and treatment of thrombosis |
| 04/18/2007 | EP1349569B1 Intrinsically fluorescent, self-multimerizing mhc fusion proteins and complexes thereof |
| 04/18/2007 | EP1343525B1 IMPROVED i MYCOPLASMA HYOPNEUMONIAE /i BACTERIN VACCINE |
| 04/18/2007 | EP1335976B1 Modifier of organelle metalbolism |
| 04/18/2007 | EP1334194B1 Imaging, diagnosis and treatment of disease |
| 04/18/2007 | EP1324652B1 Transgenic drosophila melanogaster expressing beta amyloid |
| 04/18/2007 | EP1283720B1 Recombinant or purified polyclonal antibodies for treating allergy |
| 04/18/2007 | EP1248645B1 Novel chimeric proteins and their use |
| 04/18/2007 | EP1206549B1 Basb119 polypeptide and polynucleotide from moraxella catarrhalis |
| 04/18/2007 | EP1204420B1 Trehalose producing prokaryotic cells as vaccines |
| 04/18/2007 | EP1144010B1 Prevention of chronic graft rejection by a combination of immunotoxins and costimulation blockers |
| 04/18/2007 | EP1140166B1 Adjuvant containing N-formyl methionyl peptides for vaccines |
| 04/18/2007 | EP1135160B1 Boron neutron capture therapy using pre-targeting methods |
| 04/18/2007 | EP1079843B1 Use of alfa1beta1 integrin receptor inhibitors and tgf- beta1 inhibitors in the treatment of kidney disease |
| 04/18/2007 | EP1012282B1 Cysteine rich receptors-train |
| 04/18/2007 | EP0960117B1 FIBROBLAST GROWTH FACTOR HOMOLOGOUS FACTORS (FHFs) AND METHODS OF USE |
| 04/18/2007 | EP0739414B1 Herpesvirus replication defective mutants |
| 04/18/2007 | CN1950518A Compositions and methods for characterizing, regulating, diagnosing, and treating cancer |
| 04/18/2007 | CN1950507A Recombinant varicella-zoster virus |
| 04/18/2007 | CN1950499A 黄病毒疫苗 Flavivirus vaccines |
| 04/18/2007 | CN1950399A Less immunogenic binding molecules |
| 04/18/2007 | CN1950396A 抗真菌肽 Antifungal Peptide |
| 04/18/2007 | CN1950108A Axon regeneration promoter |
| 04/18/2007 | CN1950107A Anti-IRTA-5 antibodies and use thereof |
| 04/18/2007 | CN1950106A Synthetic protein as tumor-specific vaccine |
| 04/18/2007 | CN1950100A Multi-component biological transport systems |
| 04/18/2007 | CN1948468A Hybridization immune deficiency virus strain and application |
| 04/18/2007 | CN1948343A Tetravalence single chain antibody of p53 tetra polymerized structure domain |
| 04/18/2007 | CN1947793A Application of Entamoeba histolytica for treating malignant noumenal tumor |
| 04/18/2007 | CN1947728A Method for preparing horse anti blood serum |
| 04/18/2007 | CN1947727A Anti-echidnotoxin blood serum and its preparing method |
| 04/18/2007 | CN1311077C Methods and compositions for stable transgenic plant pharmaceuticals and their use as contraceptives |
| 04/18/2007 | CN1311071C A method of treating an autoimmune disease |
| 04/18/2007 | CN1310947C Gamma-1 and gamma-3 anti-human CD23 monoclonal antibodies and use as the rapentics |
| 04/18/2007 | CN1310942C Suppressor gene |
| 04/18/2007 | CN1310906C Indole-type derivatives as inhibitors of p38 kinase |
| 04/18/2007 | CN1310678C Administration of agents for the treatment of inflammation |
| 04/18/2007 | CN1310677C Method of preparing rabies live carrier vaccine using gland virus carrier expression rabies virus bigene |
| 04/18/2007 | CN1310676C Method for improving immune response |
| 04/17/2007 | US7205392 Synergistic mixture of glycoprotein and angiogenesis inhibitor |
| 04/17/2007 | US7205390 Enzyme |
| 04/17/2007 | US7205386 Truncated CD200 |
| 04/17/2007 | US7205280 Methods of suppressing microglial activation |
| 04/17/2007 | US7205274 Hybrid peptides modulate the immune response |
| 04/17/2007 | US7205162 Crosslinked polymer (especially ethylene dimethacrylate-crosslinked polymethacrylic acid) prepared by molecular imprint polymerization and having a binding site having specificity for an imprinted molecule and a particle size of less than five microns; therapeutic and diagnostic applications |
| 04/17/2007 | US7205139 Expression vector comprising nucleotide sequences coding serine protease for use in diagnosis and treatment of thrombotic disorders |
| 04/17/2007 | US7205125 Mixed Virus-like particles |
| 04/17/2007 | US7205119 HA-1 antigen |
| 04/17/2007 | US7205108 Trp8, Trp9 and Trp10, novel markers for cancer |
| 04/17/2007 | US7205107 CATT-tetranucleotide repeat polymorphism at position-817 of the human Mif gene that functionally affects the activity of the Macrophage Inhibitory Factor (MIF) promoter in gene reporter assays |
| 04/17/2007 | US7205013 Infectious Respiratory Syncytial Viral particle for use as gene transfer tool in genetic engineering |
| 04/17/2007 | US7205001 Anticancer agents; using potassium arsenite therapy and radiation |
| 04/17/2007 | US7204993 For the protection of fish against infection by the same and other virulent strains Streptococcus agalactiae |
| 04/17/2007 | US7204992 P153 and P156 antigens for the immunodiagnosis of canine and human ehrlichioses and uses thereof |
| 04/17/2007 | US7204991 Porphyromonas gingivalis recombinant proteins and truncations |
| 04/17/2007 | US7204990 Attenuation of cytomegalovirus virulence |
| 04/17/2007 | US7204989 For diagnosis of Hepatitis E virus, use in a vaccine for the prevention of HEV in humans |
| 04/17/2007 | US7204985 Tumor necrosis factor (TNF); antibody inhibitors; immunotherapy; gene therapy |
| 04/17/2007 | US7204984 Acetyllysine-recognizing monoclonal antibody and process for producing the same |
| 04/17/2007 | US7204983 Administering to the vertebrate a composition comprising an anti-idiotype antibody, wherein the anti-idiotype antibody binds to an antibody that is specific for a lipoglycan found on the surface of the eukaryotic parasite, the lipoglycan comprising a lipid group, fucose groups, galactoseamine groups |
| 04/17/2007 | US7204982 Compositions and methods for treatment and detection of multiple cancers |
| 04/17/2007 | US7204978 Treatment and diagnosis of infertility using TGFβ or activin |
| 04/17/2007 | CA2231332C Bacterial delivery system |
| 04/17/2007 | CA2216410C Improved inactivated vaccines |
| 04/17/2007 | CA2184175C Isolated, tyrosinase derived peptides and uses thereof |
| 04/17/2007 | CA2166292C Assay for ykl-40 as a marker for degradation of mammalian connective tissue matrices |
| 04/17/2007 | CA2166118C Adenovirus vectors for gene therapy |
| 04/17/2007 | CA2162193C Lactoferrin receptor protein |
| 04/17/2007 | CA2141212C Defective adenovirus and corresponding complementation lines |
| 04/17/2007 | CA2100690C Megakaryocyte differentiation factor |
| 04/12/2007 | WO2007041694A2 Compositions and methods for treating inflammation |
| 04/12/2007 | WO2007041432A2 Cross-neutralization of hcv with recombinant proteins |
| 04/12/2007 | WO2007041397A2 Targeted pharmaceuticals and ligands |
| 04/12/2007 | WO2007041317A2 Immunomodulatory compositions and uses therefor |
| 04/12/2007 | WO2007041219A2 Compositions and methods for il13 biomarkers |
| 04/12/2007 | WO2007041190A2 Polymer-based delivery system for immunotherapy of cancer |
| 04/12/2007 | WO2007040912A2 Human monoclonal antibodies to activin receptor-like kinase-1 |
| 04/12/2007 | WO2007040711A2 Pharmaceutical formulations |
| 04/12/2007 | WO2007040636A1 Methods for reducing blood pressure |
| 04/12/2007 | WO2007040546A2 Production of recombinant protein pap 31 for the diagnosis and prevention of bartonella bacilliformis infection |
| 04/12/2007 | WO2007039761A2 Crystal structure of cd44 and its use |
| 04/12/2007 | WO2007039716A1 T cell epitopes from the 5t4 tumor associated antigen and their use in treatment of cancer |
| 04/12/2007 | WO2007039599A1 Novel sea lice vaccine |
| 04/12/2007 | WO2007039584A1 Multivalent liposomal vaccine compositions comprising polysaccharide antigens and a protein adjuvant |